Safety
Safety comes first, and only a patient and their clinical care team can decide what is safe. This is general information, not medical or legal advice.
How practices fit GLP-1 patients into care
A:Aesthetic practices integrate GLP-1 patients by timing surgery and treatments to each patient's weight stability and nutritional status, which a 2026 review says should guide surgical decisions for GLP-1 patients. The review, in the Turkish Journal of Surgery, found these drugs expand the pool of surgical candidates while raising questions about skin laxity, wound healing, and the durability of outcomes. It treats GLP-1 use as neither an absolute advantage nor an automatic contraindication in aesthetic surgery.1
A 2026 framework in Aesthetic Surgery Journal Open Forum flags at-risk patients by weight loss exceeding 10% of body weight, GLP-1 use over 6 months, or intake below 1,200 kcal a day. For those patients, procedures wait for nutritional repletion when deficiencies are present. Nutrition is improved before RF microneedling, because energy-based collagen remodeling is cofactor-dependent. The authors also advise coordinating with the prescribing physician and reassessing labs at about 3 months, though the framework awaits prospective validation.2
A 2024 commentary in the Journal of Cosmetic Dermatology says managing facial volume loss, skin laxity, and body contour changes after GLP-1 weight loss requires injectables, energy-based devices, and, in some cases, surgery.3 A practice integrates GLP-1 patients through the services it already offers, sequenced around each patient's weight loss. For more about how GLP-1 patients are changing aesthetic menus, see our GLP‑1 menu shifts.
Notice
This article is for informational purposes only. It describes published sources and gives our opinion on what they mean for running a practice. It is not medical or legal advice, it does not create a doctor‑patient or attorney‑client relationship, and it should not be used to make any medical or legal decision. Discuss treatment with a qualified healthcare provider and legal questions with a licensed attorney. What it says about any company, product, or pharmacy comes from the sources cited below, and anything beyond them is our opinion. To report an error, email lazar@fractionalaesthetics.com and we will review it.
How patients see your practice
The FAx audit scores what a prospective patient sees: search, reviews, presence, and AI. It takes two minutes to request and needs no call, and the audit arrives by email within a couple of business days, yours to keep.
More market research
Sofwave usage fees rose 60% in one quarter. What does Sofwave tell investors about practice margins?Sofwave's usage fees rose 60% to $13.3 million in Q3 2026.5 min read About half of body contouring patients were ready at a PA or NP visit. When do the rest return?A PA or nurse practitioner found about half of body contouring patients ready.7 min read Juvéderm sales fell 11.8% year over year. How often do toxin patients add filler?In 2025, 13% of US toxin treatments came with a filler treatment, down from about 21% in 2017.5 min readReferences (3)
- Turkish Journal of Surgery, Effects of GLP-1 receptor agonists on aesthetic surgery practice: A contemporary review, 2026. Peer-reviewed. https://turkjsurg.com/articles/effects-of-glp-1-receptor-agonists-on-aesthetic-surgery-practice-a-contemporary-review/doi/turkjsurg.2026.2026-4-35 Back to where you were ↑
- Aesthetic Surgery Journal Open Forum, The Impact of Glucagon-Like Peptide-1 Receptor Agonist-Induced Nutritional Deficiencies on Skin Health: A Narrative Review With a Proposed Framework for the Aesthetic Practitioner, 2026. Peer-reviewed. https://pmc.ncbi.nlm.nih.gov/articles/PMC13660798/ Back to where you were ↑
- Journal of Cosmetic Dermatology, The Role of GLP-1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health, 2024. Peer-reviewed. https://pmc.ncbi.nlm.nih.gov/articles/PMC11845967/ Back to where you were ↑